Podcasts about Digital health

Rebecca Bloom is a former employee benefits and executive compensation attorney who spent more than 25 years helping women navigate cancer, work, insurance, disability coverage, and financial survival. She is the founder and author of When Women Get Sick, a book built from decades inside the legal, workplace, and patient advocacy systems most people only discover after diagnosis.Bloom started in Big Law at Simpson Thacher handling employee benefits and compensation work she originally chose to pay off student loans. Then her mother was diagnosed with breast cancer. Suddenly the language she used in corporate law offices became the language of survival at home. Explanation of benefits forms. Coverage disputes. Second opinions. Disability protections. Medical leave. Bills no one could explain.That collision changed the direction of her life.In this episode, Bloom explains how serious illness quietly turns patients into unpaid administrators managing paperwork, logistics, financial risk, and emotional labor while trying to survive treatment. She breaks down how employer based health insurance shapes nearly every aspect of cancer care in America and why women often carry the invisible burden of protecting everyone else from discomfort while they themselves fall apart.The conversation digs into workplace power, the illusion of the healthcare “safety net,” caregiver exhaustion, and the class divide hiding underneath patient empowerment culture. Bloom explains why educated, insured women with resources still struggle to navigate healthcare bureaucracy and what happens to patients without those advantages.This episode explores cancer care, health insurance, employee benefits, patient advocacy, workplace protections, caregiving, and the structural incentives that force sick people to become project managers of their own survival.RELATED LINKSRebecca BloomWhen Women Get SickBay Area Cancer ConnectionsSimpson Thacher & BartlettFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Vasanta Pundarika built her career inside healthcare investment banking before launching Lotuspring, an advisory firm focused on women's health and behavioral health. She spent nearly 20 years advising healthcare systems, treatment providers, and growth stage companies on mergers, financing, and operational strategy while watching the industry repeatedly misunderstand the people it claimed to serve.The conversation starts unexpectedly with anthropology, bread, and language. Vasanta explains how she spent years changing the pronunciation of her own name to make other people comfortable before eventually reclaiming it. That thread opens into a much larger discussion about adaptation, identity, and what institutions quietly train people to tolerate.From there, the discussion moves into behavioral health, women delaying care, and the invisible labor that healthcare business models routinely ignore. During COVID, Vasanta noticed men's behavioral health units refilled faster than women's units. The reason had nothing to do with demand. Women were still home managing caregiving responsibilities, children, aging parents, and households while their own mental health collapsed in the background.The episode examines what happens when healthcare companies become “snazzy big brands” before building real clinical substance underneath. Vasanta describes the tension between mission and margin inside healthcare startups, private equity backed care models, and behavioral health expansion. The conversation pushes on who benefits when healthcare scales aggressively, who absorbs the operational pressure, and how patient trust erodes long before executives notice it on a dashboard.They also discuss patient advocacy culture, anthropology as systems analysis, healthcare capitalism, prior authorization, investor language, and why some clinically excellent companies never survive long enough to scale.RELATED LINKSVasanta PundarikaLotuspringWomen's Health HorizonsSakhi for South Asian SurvivorsNACDPrinceton University Anthropology DepartmentFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Healthcare companies are built to improve patients' lives. So why do so many prioritize shareholders over the people they're meant to serve?This week, Halle sits down with Eric Ries, author of Incorruptible, to unpack the rise of shareholder primacy, what it is, and why he believes it's at the root of many of society's biggest challenges. They discuss the surprising history of corporate governance, the lessons behind Novo Nordisk's century-long success, and what founders can do today to keep their companies aligned with their mission as they grow.We cover:Why shareholder primacy reshaped corporate America (and where we go from here)How Novo Nordisk's unusual ownership structure may have saved GLP-1 researchThe simple governance change that could preserve your company's mission for decadesHow boards, investors, and acquisitions can slowly pull companies away from their original purposeThe founder mistakes that make mission drift almost inevitableAbout our guest:Over the last two decades, Eric Ries's ideas about continuous innovation, long-term thinking, governance, and market reform have reshaped company building and management practices. He is the creator of the Lean Startup method, and the author of two New York Times bestsellers The Lean Startup and Incorruptible; The Leader's Guide; and The Startup Way. As a founder, he has put his own ideas into practice with The Long-Term Stock Exchange (LTSE); Answer.AI, an AI R&D lab; Virgil, a legal services startup; and IMVU. On The Eric Ries Show, he talks with world-class technologists, thought leaders, and executives building for the long-term. Check out his book, Incorruptible: Why Good Companies Go Bad…and How Great Companies Stay Great—

Hosts: Megan Antonelli and Janae Sharp Join hosts Janae Sharp and Megan Antonelli for Five Good Things: A rapid-fire segment highlighting positive developments in digital health. Janae and Megan share insights on recent innovations, successful implementations, and emerging trends that are driving progress in healthcare technology. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Send us Fan MailAmerican healthcare spends an estimated $110 per member per month just to administer itself, before a single service is ever delivered. Most of that cost exists because health data still cannot move freely between the systems that need it.Michael Meucci, CEO of Arcadia, joins host John Driscoll to discuss why two decades of interoperability policy have failed to solve the data fragmentation problem facing health systems and payers, and why liberating that data and redirecting the administrative spend it currently requires could be the single biggest lever available for improving both the cost and quality of American healthcare.

Touchless patient monitoring is making it easier to track patient health without adding more burden to clinicians. In this episode, Nayan Patel, Senior Vice President and General Manager of Transformation and Digital Health at Neteera, discusses how contactless patient monitoring can bridge care gaps and alleviate nurse burnout. Drawing on his extensive background as a healthcare CIO, Nayan emphasizes that new technology must actively solve workflow bottlenecks rather than adding tasks to a clinician's plate. He explains how Neteera's FDA-cleared, camera-free radar technology continuously tracks vital signs like heart and respiratory rates directly through bedding and clothing. Ultimately, by seamlessly integrating these passive alerts into daily routines, health systems can predict patient deterioration days in advance and smoothly transition toward virtual care models. Tune in to learn how touchless monitoring could shape the future of patient care! Resources: Connect with and follow Nayan Patel on LinkedIn. Follow Neteera on LinkedIn and explore their website.

This week on Pulse: Hot Topics, Louise and George look at what happens when digital health stops being a pilot and starts being a system decision — and why, again and again, the technology isn't the hard part.Portugal Buys AI Physiotherapy for an Entire Country — Portugal's National Health Service has contracted Sword Health to make AI-supported physiotherapy available to all 10 million citizens, free after a prescription, prompting the question: are governments shifting from buying AI software to buying AI-delivered healthcare?AI and Accountability: The First Complaints Land — The UK's first complaints about clinicians' inappropriate use of AI have reached professional regulators, arriving well before the evidence base and accountability frameworks are ready.95% of Health Apps Have No Verifiable Regulatory Approval — Rudolf Wagner's analysis found that of nearly 96,000 apps qualifying as Software as a Medical Device, 95% had no verifiable CE marking or FDA authorisation, leaving consumers with no easy way to know what they're actually using.Doctors Want Wearable Data, But Can't Use It — A new AMA(US) survey found 97% of physicians would review data from a patient's wearable, but no more than 6% have actually integrated it, blocked by missing standards, workflow fit, reimbursement and liability.Virtual Care Could Transform Residential Aged Care — Australian researchers found virtual care between aged care homes and GPs improves access and reduces unnecessary hospital visits, but is undermined by poor integration, unreliable networks and limited staff training — the technology works, the system around it doesn't.With Thanks to Datacom:Download the Executive Briefing Playbook LinkResources:Sword Health partners with Portugal's National Health Service LinkFirst complaints made over clinician use of AI, HSJ via Patient Safety Learning Hub LinkEnsuring the clinical impact of medical artificial intelligence, Andreoletti et al., Lancet Digital HealthLinkAnalysis of Software as a Medical Device (SaMD) Compliance in App Store Applications, Rudolf Wagner LinkDocs unable to harness wearables data, survey finds, Axios LinkVirtual care could benefit residential homes – study, Pulse+IT LinkVirtual care in residential aged care homes, Journal of Medical Internet ResearchLinkRecommendations:Clinicians – be part of the research into clinician use of AI, open globally LinkStandards Australia telehealth and virtual care standard LinkThere's An AI For That (TAAFT) newsletter LinkAge-Friendly Futures newsletter, George Gouzounis Link"Welcome to the Land of the Free" — World Cup song by Jason Stills LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Send us Fan MailWhen a teenager expresses suicidal thoughts to an AI chatbot, what happens next?In this clip from our episode “Who Sets the Rules for AI in Medicine?”, hosts David E. Williams and John Driscoll and Dr. John Whyte, CEO of the American Medical Association, break down why minors need stronger protections from AI chatbots than adults do, and why the line between a wellness app and a medical device matters more than the industry wants to admit.Listen to the full episode here

Technology has transformed general practice, but what impact is it having on the people using it every day? In this podcast, Laura Edwards, GP and Joint CEO of Wessex LMCs, is joined by Dr Francesca Dakin, Senior Researcher in Digital Health at the University of Oxford, to discuss a study exploring the hidden side of technology use in primary care.

Brad Power spent years advising major corporations on systems design, process engineering, and decision making before lymphoma shoved him into the patient side of American healthcare. Instead of accepting the experience at face value, he started reverse engineering the machinery around cancer itself. Brad is the founder of Cancer Patient Lab and Open Cancer AI, two projects built around a blunt reality most patients discover too late: the healthcare system rewards people who know how to navigate it. Everyone else risks getting steamrolled by information asymmetry, insurance barriers, administrative friction, and institutional incentives designed around efficiency instead of human survival.The conversation starts with Harvard Business Review and Tumblr blogs before moving directly into the darker architecture underneath modern cancer care. Power explains how hospitals optimize for throughput, how insurance companies reward operational consistency over personalized medicine, and why many patients quietly end up needing a crash course in oncology, reimbursement policy, and behavioral psychology while fighting for their lives.The discussion digs into CAR-T therapy, functional testing, AI assisted decision support, and the growing collision between personalized medicine and standardized care pathways. Power argues that engaged patients often get better outcomes because they learn how to push for off guideline treatments, contest denials, and ask smarter questions. The counterpoint lands hard: patients should never have needed to become experts in the first place.The episode also explores the cultural consequences of AI entering cancer care. OpenAI advertising, data privacy, trust erosion, pharmaceutical influence, and “agentic AI” all collide inside a healthcare economy already drowning in distrust. Power sees artificial intelligence as a force multiplier for patient literacy and access. The larger system still decides who gets approved, who gets delayed, and who gets left behind.By the end, the conversation lands exactly where modern healthcare keeps forcing people to land: survival increasingly depends on learning how the machine works before the machine works on you.RELATED LINKSBrad PowerCancer Patient LabOpen Cancer AIHarvard Business ReviewResearch to the PeopleCAR T Cell TherapyFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

July 14, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: IM8 secures up to $1B in non-dilutive financing from General Catalyst after hitting $200M revenue, expecting $300M ARR by year end WHO projects annual cancer cases will climb from 21M to nearly 35M by 2050, driven by aging, obesity, and healthcare inequities Rock Health reports $10.5B raised across 273 digital health deals in H1 2026, the strongest pace since 2021 as capital concentrates Today's episode is brought to you by AIIR — a modern communications and experiential agency for health, wellness, fitness, and performance brands. From earned media to events and creator-led campaigns, AIIR helps companies sharpen their story, earn attention, and build trust that compounds. Visit https://aiir.agency to learn more. More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co

Over the last decade, the number of drug candidates entering development has doubled, yet the number of successful drug approvals remains flat at ~50 per year.This week, we sit down with Formation Bio founder and CEO Ben Liu. His company has raised more than $600 million to build what he hopes will become the first new enduring pharmaceutical company in decades, powered by AI. Ben explains why he believes clinical development, not drug discovery, is becoming the industry's biggest bottleneck, and how AI could fundamentally change the economics of bringing new medicines to patients.We cover:Why there hasn't there been a big pharma company created since the 1980sWhich drug categories Ben believes could become the next GLP-1s and reshape healthcareWhy Formation Bio chose to become a pharmaceutical company instead of selling softwareThe real bottleneck in bringing medicines to patientsBen's roadmap for how AI will transform drug development over the next 10 to 20 yearsAbout our guest:Ben Liu is the co-founder and CEO of Formation Bio. He received his DPhil at Oxford as a Rhodes Scholar, leveraging machine-learning, AI, and big-data to develop diagnostics and therapeutics for Parkinson's and Alzheimer's disease. During his graduate work, he observed the way clinical trials bottlenecked the development of new treatments for patients, compelling him to start Formation Bio.Before Formation Bio, Ben graduated from Yale where he was awarded the college's highest honor at graduation and received his MPhil with distinction in Computational Biology from the Department of Applied Mathematics and Theoretical Physics at Cambridge as a Paul Mellon Fellow. Ben also serves as an Advisor to Harvard Business School's MS/MBA Program in Biotechnology.—

Why AI and Digital Health Pilots Die Before They Scale | Dr. Sarah Matt, The Borderless Healthcare Revolution Health systems spend billions on transformation that works in the boardroom and collapses at the clinical unit. Dr. Sarah Matt, a surgeon turned health technology executive, explains why most AI and virtual care initiatives fail at adoption rather than design, and how her Five Pillars of Access give leaders a practical way to evaluate what will actually scale. A direct conversation about trust, financial sustainability, and building care models that stick. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Send us Fan MailEighty-one percent of physicians are already using AI in practice, more than double the rate from just three years ago. The tools are moving faster than the rules, and nobody has agreed on who gets to write them.Dr. John Whyte, CEO of the American Medical Association, joins hosts David E. Williams and John Driscoll to discuss why the medical community needs to lead the conversation on AI guardrails rather than wait for Washington to catch up, and why the most urgent regulatory question right now involves AI chatbots in mental health, where one in six American adults are already using them with no meaningful oversight in place.

In this episode of Investor Connect, Hall welcomes by Laura Hilty, Principal at HealthX Ventures and Chief Strategy Officer at Ignite Data, to discuss her path from Epic to building and launching seven software products at a clinical research startup, supporting acquisitions, and ultimately seeing the business sold to Blackstone for $5B—before moving into early-stage health tech investing. Laura shares how digital health opportunities are shifting as Epic expands into AI, creating new investment risk and pushing startups toward deep niches and tech-enabled services Epic won't replicate, like devices or clinician staffing. We also cover the FDA's push toward real-time clinical trials and questions around participant-level data, plus innovations addressing clinician shortages through automation and peer support, including Sober Sidekick's relapse prediction. Laura closes with advice on proving product-market fit before VC, defining moats in an AI-driven world, and avoiding overly frothy early valuations. Visit HealthX Ventures at www.healthxventures.com/ Reach out to at www.linkedin.com/in/laura-hilty001/ ________________________________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https:/_/tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound.

By the time the paper hit version 71, Dr. Nirosha Murugan had already done the hard part. The data were real. The experiment had worked. A team of researchers had used a wearable bioreactor to trigger limb regeneration in frogs, a result with obvious implications for regenerative medicine. But the science still wasn't getting over the line. The problem wasn't the work. It was the translation.On this episode of Standard Deviation, host Oliver Bogler talks with Dr. Nirosha Murugan, a biophysicist and Tier II Canada Research Chair in Tissue Biophysics at Wilfrid Laurier University, about what happens when a scientist working at the edges of quantum biology, bioelectricity, and tissue regeneration runs headfirst into the unwritten rules of academic publishing. Murugan's research asks biologists to think beyond molecules and chemistry alone, and to consider the physical signals, electromagnetic fields, and invisible forces that shape development and healing. It is ambitious science. It is also exactly the kind of work that can make gatekeepers nervous.Bogler follows Murugan through the less glamorous part of discovery: the hidden curriculum of getting a paper published, securing scientific credibility, and learning that data do not simply “speak for themselves.” Murugan describes how jargon buried the pitch of her own work, how a lack of editorial support left her at a disadvantage, and how the JEDI program at the Life Science Editors Foundation paired her with a former journal editor who taught her how to structure a manuscript, write a cover letter, and survive peer review.The result was publication in Science Advances, but the larger story is about power. Who gets taught the rules of biomedical research. Who has access to grant writers, editors, and institutional polish. Who is left to brute-force their way through the maze. And how one scientist, having finally found the map, now makes sure her own trainees do not have to learn it the hard way.RELATED LINKSDr. Nirosha Murugan⁠Wilfrid Laurier University⁠Life Science Editors Foundation⁠JEDI Program⁠Science Advances paper on limb regeneration⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week on Pulse: Amplify, Louise and George sit down with patient advocate and AI Champion, Hugo Campos.Hugo Campos has spent nearly two decades fighting for a simple principle: patients should have access to the data generated by their own bodies. After discovering that his implanted cardiac defibrillator was sending information to clinicians and manufacturers—but not to him—he became one of the world's leading advocates for patient data rights.In this episode, Hugo explains why generative AI changes everything. Rather than waiting for hospitals or vendors to build better tools, patients can now create their own AI-powered applications, analyse their own health data and ask questions that matter to them.We discuss patient-directed AI, the rise of personalised "N-of-1" healthcare, critical AI health literacy, and why the next wave of healthcare innovation may come from patients themselves—not institutions.Connect with Hugo on LinkedInResources – open source, freely available by Hugo:https://caihl.org/ (framework of critical ai health literacy)https://openkp.org/ (mcp server for access to provider data)https://myheartdata.org/ (19 years of Hugo's own echo data)https://hugotronic.com/ (longitudinal data from Hugo's implantable defibrillator)https://endothelial.org/ (explains endothelial dysfunction, built for Dave)Hugo's newest app:https://hugoscore.org/ (evaluates patient-facing health apps throught he CAIHL lens)Visit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Dr. Jess Peatross trained in conventional medicine and worked as a hospitalist before she started questioning why so many chronically ill patients kept getting worse inside the healthcare system she trusted. Her perspective carries weight because she spent years following every protocol exactly as taught before walking away from hospital medicine entirely.Raised in Huntington, West Virginia during the opioid crisis, she entered medicine believing the system existed to heal people. Instead, she found hospitals driven by billing codes, liability management, and pharmaceutical dependence while patients with chronic illness, autoimmune disease, mold exposure, and chronic pain cycled endlessly through appointments and prescriptions.Dr. Peatross explains what pushed her toward functional medicine, cannabis therapy, and prevention focused care after watching patients improve only after leaving conventional treatment pipelines behind. The conversation tackles physician burnout, chronic illness stigma, healthcare incentives, and the growing collapse of trust between patients and institutions.The discussion also moves into supplements, environmental toxins, ultra processed food, and the uncomfortable economics behind keeping people permanently sick but continuously billable. Dr. Peatross describes the professional backlash that comes with challenging medical orthodoxy while Matthew connects her experience to the broader erosion of public trust across American healthcare.Together they unpack what happens when patients stop believing the system can help them and start searching elsewhere for answers.RELATED LINKSDr. Jess PeatrossInstagramMarshall UniversityBrave New WeedFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

They built a $1.2 billion healthcare AI company in under three years, but they say the hardest part of healthcare AI isn't the AI.This week, Halle sits down with Assort Health co-founders and co-CEOs Jeffery Liu and Jon Wang, whose company reached a $1.2 billion valuation in under three years. They discuss why building great healthcare AI takes far more than good models, how they scaled from 15 employees to nearly 250 in a year, and what they've learned from more than 190 million patient interactions. They also share why voice AI is harder than it looks, how they're thinking about building durable moats in the age of foundation models, and why helping patients navigate the healthcare system may be one of AI's biggest opportunities.We cover:The AI role suddenly showing up at every healthcare startupThe surprising demographic that gives AI voice agents the highest satisfaction scoresHow healthcare AI is shifting from single-purpose tools to platforms that remember patients across every interactionWhy the biggest moat in healthcare AI may not be the model itselfThe biggest misconception investors have about moats in healthcare AIHow to triple your team without losing the culture that made the company successful—

Before the Next Crisis: A Preventioneer's Framework for AI, Trust, and Healthcare Leadership Healthcare leaders know the pattern. Warning signs appear. Evidence accumulates. Institutions hesitate. And by the time action is taken, the cost, human and financial, is already enormous. Right now, that pattern is playing out across AI deployment, eroding public trust, and simultaneously weakening fragile health systems. On this episode of Digital Health Talks, physician-scientist and biostatistician Dr. Barry R. Davis brings a framework health leaders can actually use. Drawing on decades leading landmark prevention trials and his new book The Preventioneers: Diseases, Disasters, and the Discoveries That Changed Our World (Johns Hopkins University Press, May 2026), Dr. Davis breaks down why evidence alone rarely drives action, what trust has to do with it, and what the leaders who successfully broke the cycle actually did differently. If you are responsible for AI governance, patient trust, or building a prevention-first culture inside your health system, this conversation is for you. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

This week on Pulse: Hot Topics, Louise reports in from a heatwave in the French Alps while George braces for a Sydney winter — before the pair work through five stories on a single throughline: AI adoption by clinicians and patients is racing ahead of the institutions meant to govern it.They discuss why more than half of UK GPs are now using generative AI in clinical practice, how an AI system analysing a routine ECG helped save a patient's life, the emergence of agentic AI capable of managing clinical workflows, a robotic platform accelerating cancer drug discovery, and an Australian-developed wearable "stethoscope sticker" designed to continuously monitor heart and lung sounds.Resources:Half of UK GPs Now Use AI Blease et al LinkAI Flagged a Failing Heart Hartman et al Nature LinkAgentic AI Comes to Medicine Topol, Ground Truths LinkAIME, Lievin et al Nature LinkMIRA, Ferber et al Nature LinkUpDoc FDA-clearance announcement — PRNewswire LinkShrestha, Innolitics LinkPersistern Cells, Sun et al., ScienceAdvances LinkThe "Stethoscope Sticker" Dang et al., LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Why Clinical Conversations Matter: Leading Human-Centered AI in Healthcare Host Russ Branzell, President and CEO of CHIME, connects with Dr. Shiv Rao, Founder and CEO of Abridge and practicing cardiologist, for a compelling discussion on the evolving role of AI in clinical care. Drawing from his unique vantage point at the intersection of medicine and technology, Dr. Rao shares how firsthand clinical experience is shaping the development of ambient, generative AI tools designed to reduce cognitive burden and restore focus to patient care. Together, they examine the growing importance of trust, the responsibility of leaders to guide ethical AI adoption, and how human-centered design principles can scale alongside rapid innovation. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Send us Fan MailThe COVID-19 pandemic proved vaccine platforms can move at unprecedented speed. It also revealed how dangerously narrow the world's response really was, built almost entirely on a single technology.Dr. Dan Barouch and Kris Brown, Co-Founders of Vector Sciences, join host David E. Williams to discuss why durable pandemic preparedness depends on having multiple vaccine platforms rather than just one, how their Rheovax platform uses mucosal immunity delivered through the nose to block transmission rather than just prevent severe disease, and why public trust in vaccines depends on being honest about what each technology can and cannot actually do.

Farla Efros is a senior retail executive and former CEO who built and sold companies before facing her own breast cancer diagnosis. She brings that same operational mindset into a healthcare system that expects patients to manage complexity while they are at their most vulnerable.She was on a client call in Spain when the diagnosis came through. A clear mammogram had missed it. An MRI caught it. Within hours, she was ordering binders, building a plan, and structuring her treatment like a turnaround strategy. Every appointment became a meeting. Every doctor faced an agenda with dozens of questions. She paid out of pocket for PET scans that were denied and hired a third party firm to validate her treatment path when her own doctors resisted outside input. The conversation tracks what happens when a high-functioning executive enters a system built on delay, denial, and fragmentation. Efros describes negotiating for tests, managing physician relationships, and assembling an “executive board” of advisors across conventional and alternative care. She calls the experience “the worst client I ever had,” exposing how administrative burden shifts onto patients and families.The tension sits between what worked for her and what is inaccessible to most. Her approach requires confidence, time, and fluency in navigating power. The system rewards that behavior while quietly failing patients who cannot replicate it. Insurance coverage still left her paying out of pocket. Doctors pushed standard protocols over precision medicine. Survivorship offered little support once treatment ended.This episode examines how cancer care operates as a series of incentives rather than a coordinated system, and why patients are forced to become operators just to get through it.RELATED LINKSFarla EfrosFarla Efros on LinkedInF*ck CancerF*ck Cancer on AmazonAccentureCTOAMPULL QUOTES“I treated cancer like the worst client I ever had.”“They wouldn't approve the test, so I paid for it myself.”“Every appointment was a negotiation.”FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

July marks five years of The Heart of Healthcare, and we're grateful for every listener who's tuned in. If you've enjoyed the show, please show your love by leaving us a review!This month, Steve and Halle take stock of an industry where capital is concentrating, incumbents are making big bets, AI is moving from promise to early proof points, and a public health crisis is quietly building in the background.We cover:The digital health funding numbers that just dropped, and what they reveal about where the money is really goingA $12 billion deal that has the RCM world buzzingThe Nature study that has clinical AI companies on edgeA new entrant into medical imaging that nobody saw comingThe public health crisis that sports betting built, and why healthcare isn't talking about it enoughEarly data out of Utah that could change how we think about AI in clinical settingsLinks:IPO Watch List: https://halletecco.substack.com/p/the-digital-health-ipo-watchlistEnsemble Health / Thoreau deal: https://hitconsultant.net/2026/06/18/thoreau-makes-strategic-investment-in-ensemble-health/Nature Medicine AI study: https://www.nature.com/articles/s41591-026-04431-5Midjourney Medical: https://www.theverge.com/ai-artificial-intelligence/952011/midjourney-medical-ai-ultrasound-scanDoctronic pilot outcomes: https://commerce.utah.gov/wp-content/uploads/2026/05/Doctronic-Outcomes-May-2026.pdf—

S1E4: What governance is supposed to mean in digital health On this episode host Shahid Shah features the failures of governance committees in healthcare organizations and the resulting decision debt. He covers how governance failures create decision debt, which accumulates when organizations consistently delay or avoid making choices, leading to shadow IT, increased costs for vendors, and overall organizational slowdown. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Ebola, AI, and Prevention as the Real Cost Cure Two outbreaks are spreading right now, an Ebola strain with no approved vaccine and a hantavirus that crossed dozens of borders before anyone connected the dots. Both were caught late, and that lag is expensive, in lives and in dollars. Dr. Ashish Jha, former White House COVID-19 Response Coordinator and now Co-Founder and CEO of BioRadar, joins Megan Antonelli to connect early detection to the cost and quality levers health system leaders pull every day. The throughline is simple and underused: prevention is not only good medicine, it is one of the strongest cost-control strategies in healthcare. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

“Stories … are powerful tools that can help us make sense of our lives,” says physician-scientist Maya Adam. She now combines visual storytelling and health education to create animations that go beyond the barriers of language and culture to convey important health messages. The subject matter ranges from vaccine acceptance and addiction to mental health and nutrition. These emotionally engaging narratives – often without a single spoken word – are more effective than traditional pamphlets and lectures, Adam says. Visual stories have the potential to achieve “near-universal understanding” that can support better health outcomes, she tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Maya Adam Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces guest Maya Adam, a professor of pediatrics and infectious disease from Stanford University. (00:03:43) From Ballet to Medicine How Adam's background shaped her approach to health education. (00:05:02) Why Stories Work Why lived experience makes evidence-based health recommendations more meaningful. (00:06:17) The Story Creation Process Adam's techniques for creating effective scalable health stories on any topic (00:09:20) Real World Stories Adam shares some particularly challenging topics the team has created stories for (00:11:10) Global Accessibility Designing stories and characters that can resonate across cultures and contexts. (00:12:38) Measuring Impact Using technology to run trials to test and measure impact (00:15:23) Iterating the Message Adapting and changing approaches to create the most effective message (00:17:53) AI and Storytelling How AI is beginning to affect health communication and creative production. (00:19:45) Testing Human vs. AI Art A trial comparing responses to human-created and AI-generated health storytelling. (00:25:42) Human-in-the-Loop AI How AI may best support artists and clinicians by reducing burden rather than replacing (00:27:43) Future In a Minute Rapid-fire Q&A: stories, collaboration, media, and the future of health communication. (00:29:44) Conclusion   Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

While Elsevier's most recent Clinician of the Future Report shows increasing adoption of artificial intelligence tools among physicians and nurses, and optimism that they will improve quality of care in the future, a majority raised concerns about trust and reliability. To increase the level of trust, 60% said transparent citations of evidence-based and peer-reviewed research will be key. How to provide that transparency is our focus today as Raise the Line host Lindsey Smith welcomes Elsevier colleagues Rhett Alden and Raman Kaur to guide us through the complexities involved, including the concept of traceability and what role it plays in how AI tools such as Elsevier's ClinicalKey AI are built and deployed.  “Traceability changes the confidence that a clinician has in an AI tool so that they aren't trusting the AI, they're trusting the underlying evidence they're consuming from the AI-assisted platform,” says Raman, who brings years of experience as a primary care practitioner to her work.  It's also important, Rhett adds, to provide additional information, pulled from both the clinician's query and the patient's medical record, to inform clinical thinking. “ClinicalKey AI can be more than a response engine by establishing a larger context to provide a more precise answer for that individual patient.” In this thought-provoking discussion, these experts also provide insights on: Mitigating bias in AI results; Using AI responsibly with sustainability in mind; What type of clinician will benefit most from AI Mentioned in this episode: ClinicalKey AI Clinician of the Future Report If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Mark Clermont is the CEO of Cecelia Health, and Wendi Mader is the company's Chief Commercial Officer. Cecelia is a virtual multi-specialty medical practice, licensed in all 50 states, that helps employers, payers, health systems, and life sciences companies manage chronic and cardiometabolic disease and bring down the cost of care. It's not a point solution. It's a medical practice that prescribes and manages medication (including GLP-1s, from prescribing through titration and side-effect management), runs intensive nutrition therapy, and handles behavior and lifestyle care, all through a team of RNs, RDs, certified diabetes educators, and physicians. The model is built to extend primary care, not replace it, and to coordinate across specialists instead of adding one more disconnected program.Mark and Wendi's argument is simple: chronic disease isn't winning because we lack apps or tools. It's winning because care is fragmented and nobody's tying it together. GLP-1s are making that worse before they make it better. They're the first drug class with indications spanning diabetes, obesity, sleep apnea, fatty liver, and soon addiction, which means a single patient can suddenly need four specialists who don't talk to each other. Cecelia's bet is that a multi-specialty practice can be the layer that connects all of it.We get into:Why chronic disease keeps winning even though there are more apps, tools, and wellness programs than ever, and what point solutions got wrongWhat actually happens to a patient with diabetes and high blood pressure inside Cecelia's model versus the system todayWhy GLP-1s are the first drug class to cross medical specialties, and why that's making fragmentation worse right nowThe patient on a high-dose GLP-1 and an SSRI who almost ended up in the ER, and what the direct-to-consumer prescriber missedHow the US can rank dead last among developed nations and still be the system Mark wouldn't trade for anywhere elseWhere the industry is over-indexing on AI in chronic care, and where Wendi thinks tech actually belongsThe specialty shortage, healthcare deserts, and rural-health funding, and how virtual coordinated care reaches patients brick-and-mortar can'tWhat's different for patients five years from now if Cecelia gets this right—Brought to you by: Sage Growth Partners — Value-focused strategy and marketing for growth-driven healthcare organizations. — Where to find Jared: • X: https://x.com/jaredstaylor • LinkedIn: https://www.linkedin.com/in/jaredstaylor/

A lot of digital health pilots do not fail because the idea is bad. They fail because the care model, workflow, staffing, and financial design were never fully built. This episode features a presentation from the ROI-Centered Care Summit, produced by Bright Spots Ventures in partnership with TytoCare and the American Telemedicine Association (ATA). In this episode, Reshma Gupta, MD, Chief of Population Health and Accountable Care at UC Davis Health, shares why so many AI and digital health pilots stall,  and what it takes to redesign them into models that are operationally viable, financially sustainable, and built to scale. Using UC Davis Health's hypertension remote patient monitoring program as a case study, Reshma walks through what broke in the original pilot, including slower ramp-up, unclear vendor role design, returned device logistics, and delayed billing capture. She then explains how her team rebuilt the program into a 6-month model with clearer workflows, stronger local clinical support, and a more sustainable financial structure. You'll hear how UC Davis: Redesigned RPM with a local MA, RN, pharmacist, clinician support, and vendor MA model Built a 6-month patient journey with education, medication review, and monthly nurse and pharmacy visits Improved blood pressure outcomes from 146/81 pre-enrollment to 126/73 at program completion Reframed success around workflow fit, patient engagement, billing discipline, and ROI Key topics include why pilots fail, how to match the model to the right patient population, the importance of role clarity and billing optimization, and what health systems should think through before launching the next digital health program. If you are a health system leader, population health executive, digital health leader, or care transformation strategist trying to move beyond pilots and into sustainable performance, this episode offers a practical blueprint grounded in real-world lessons. Link to Dr. Reshma Gupta's Presentation:  Bio: Dr. Reshma Gupta is a transformative healthcare executive with experience leading large-scale healthcare transformation across complex health systems and national payment reform initiatives– dedicated to innovation in population health, affordable healthcare, and social justice. With expertise in clinical and operational transformation, digital strategy, and policy, she has consistently driven high impact initiatives. Through the University of California Office of the President, she co-develops system-wide population health strategy across multiple campuses, social needs integration, and high-risk patient management initiatives including tech-enabled care and keeping patients healthier at home. As Chief of Population Health and Accountable Care at University of California Davis Health, Dr. Gupta oversees the enterprise-wide population health and accountable care portfolio to operationalize and modernize care pathways across inpatient and outpatient settings, standing up quality and equity improvement systems, and launching digital health and AI platforms. Nationally, she has advised the CMS Innovation Center on primary care transformation and advanced payment models and currently serves as an advisor to state and federal agencies on affordability and health system delivery reform. Connect with Dr. Reshma Gupta: https://www.linkedin.com/in/reshma-gupta-md-mshpm/ Thank You to Our Episode Partner, TytoCare. TytoCare enables health systems and plans to deliver high-quality remote exams anytime, anywhere. Their FDA-cleared devices and AI-powered diagnostic platform support virtual specialty care, school-based programs, and home health models, reducing unnecessary ED visits and improving patient experience. To learn more, visit tytocare.com. Schedule a Meeting with a Senior Leader at TytoCare: To explore how TytoCare can help your organization expand virtual specialty access and improve care coordination, reach out to jtenzer@brightspotsventures.com  to schedule a meeting. About Bright Spots Ventures: Bright Spots Ventures exists to help healthcare organizations accelerate the adoption of what's actually working.   Healthcare does not suffer from a lack of innovation. It suffers from slow adoption, fragmented learning, and limited trust between stakeholders. For example, one health plan or provider may solve a major operational or clinical challenge while others spend the next 5–10 years rediscovering the same answer.   We close that gap by creating trusted environments where health plans, providers, and innovators can share practical strategies, operational lessons, and scalable models that drive measurable improvement.   Through the Bright Spots in Healthcare podcast, leadership councils, executive roundtables, curated events, and strategic advisory work, we help organizations build credibility, strengthen strategic relationships, and accelerate the spread of proven ideas across healthcare.  

Send us Fan MailGLP-1 drugs were designed for weight loss. Now they may be showing up in cancer research in a way nobody expected.In this clip from our episode “The Business & Science Behind the GLP-1 Boom”, hosts David E. Williams and John Driscoll break down what the 2026 ASCO annual meeting revealed about GLP-1s and their potential to reduce cancer progression in lung, breast, colorectal, and liver cancer.Listen to the full episode here

In 2020, Emily Mendenhall drove from Washington, DC to Okoboji, Iowa, a town of 800 that swells to 200,000 every summer, and walked into a pandemic that looked nothing like the one dominating national headlines. Inside gas stations and bars, masks marked you as an outsider. In one stop, a man told her family they would not be served if they kept theirs on. Her 6 year old daughter cried, confused. Mendenhall, a medical anthropologist at Georgetown University, did what she always does. She started asking questions. Over months, she interviewed neighbors, former classmates, and local officials, including her own brother in law who helped lead the local COVID response. The result became Unmasked, a case study in how community identity, economics, and politics shaped public health decisions in real time. That work led directly into her latest book, Invisible Illness: A History, from Hysteria to Long COVID, where she tracks a much older problem. Patients with chronic illness, especially women, often fail to meet medicine's demand for proof. Without a clear diagnosis, they lose access to care, insurance coverage, and legitimacy. Mendenhall argues that long COVID did not create this failure. It exposed it.This conversation centers on how healthcare systems reward certainty and punish complexity. Long COVID clinics send patients to 17 specialists without resolution. Insurance structures require diagnoses that many conditions cannot provide. Medical training still struggles to integrate trauma, mental health, and chronic disease into a coherent model of care.Mendenhall brings lived experience into the conversation. After COVID, she dealt with months of fatigue and escalating anxiety that altered her baseline health. She does not claim the label of long COVID, but she understands how quickly the system becomes harder to navigate once symptoms stop fitting clean categories. The stakes are not theoretical. In the United States, access to healthcare, disability benefits, and treatment still depends on whether a condition can be measured, coded, and reimbursed. For millions living with invisible illness, the burden of proof becomes the illness itself.RELATED LINKSEmily MendenhallInvisible Illness: A History, from Hysteria to Long COVIDScience PoliticsGeorgetown UniversityFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Digital health funding is heating up—but where are the dollars going? And what does it mean for health systems' digital health strategies? In this live episode, recorded at Advisory Board's Research Summit, host Abby Burns sits down with Megan Zweig, President and CEO of Rock Health Advisory, for an update on what's going on in the world of digital health funding. Together, they unpack what investment activity looks like and explore questions around what constitutes an investable thesis in 2026, how health systems are—or could be—engaging in the startup ecosystem, and what it takes to be a good incubation partner. We're here to help: Episode | 298: Battle of the bots? Separating AI hype from value in revenue cycle Episode | 254: Stop searching for the “perfect” AI product and do this instead Playlist | Radio Advisory Tech and AI playlist Playlist | Radio Advisory Provider Strategy and Financial Outlook playlist Research | AI in healthcare: Evaluating promising use cases Rock Health Want to see a live recording of Radio Advisory? Register for an Advisory Board summit and get the insights your organization needs to navigate uncertainty and build lasting resilience. The role of pharmacists in cardiometabolic care A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Back by popular demand, 3x Heart of Healthcare guest Eric Larsen joins Steve to answer listener questions on healthcare's AI revolution. Drawing on the ideas behind his latest essay, Healthcare's Oppenheimer Moment, Eric argues that healthcare may be approaching a once-in-a-generation inflection point, and discusses what leaders need to understand before it's too late.We cover:Whether foundation models will eventually outperform healthcare-specific AI companiesWhy healthcare remains stuck in AI pilot projects while the technology races aheadThe biggest obstacle to clinical AI adoptionWhy liability may be the most important (and least discussed) issue in healthcare AIEric's controversial take on how AI will reshape the healthcare workforce—Links:Eric's essay is available here —

The Long View: Building a Health Organization Ready for the Next Decade of AI What does it take to build a health organization that will still be running on a strong digital and AI foundation in five years, ten years, or twenty? In this closing conversation, John Henderson, Vice President and Chief Information and Digital Officer at Rady Children's Health, takes the long view. Drawing on his work leading the digital integration of CHOC into Rady Children's Health, launching private generative AI platforms to support clinical and administrative work, and building an AI-ready data infrastructure that reaches beyond the EHR, John shares what it actually takes to align your organization around a multi-year digital vision. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

AI couldn't cure his mother's stage 4 cancer. It caught three near-fatal errors, found a same-day appointment, and helped her leave on her own terms. When Pratik Desai's mother was diagnosed with stage four duodenal adenocarcinoma — a rare cancer with roughly 3,000 US cases a year — she was nearly discharged without an oncology appointment. Over the next 76 days, Desai used AI at her bedside, from 5am to 10pm, to understand each report, prepare for every appointment, and push a stretched health system to move at the pace her diagnosis demanded. This is a frank account of where AI helped, where it didn't, and the line he refuses to cross. This is a 1:1 interview in The Agentic Patient — a Faces of Digital Health series on how patients and caregivers actually use AI: which tools, which prompts, and which guardrails. GUEST Pratik Desai — New Jersey-based AI practitioner; caregiver and builder of a free, local AI tool for patients HOST Tjaša Zajc — Founder & host, Faces of Digital Health / The Agentic Patient WHAT THE CONVERSATION COVERS - Using AI to interpret a biopsy report and push for a same-day "stat" CT scan - Why AI and the doctors agreed on the care — and clashed on the speed - Finding a same-day oncology appointment through an AI-assisted network search - An error-riddled CT report the AI refused to read — and what it did to trust - Running three Claude "personas" as built-in second and third opinions - A local, open-source AI tool that keeps medical data off the cloud - How to prompt as a patient or caregiver: awareness, knowledge, advocacy — not diagnosis - Where AI failed him: prognosis, and the rule he broke under pressure - Defining quality of life when the outcome is already known CHAPTERS 0:00 How patients use AI — and the guardrails 1:20 Day one: a healthy mother, a diagnosis no one would name 3:34 The first prompt, and pushing for a stat CT scan 7:43 Using AI in the open: agreement on care, friction on speed 9:35 The counterfactual: 76 days with AI at the bedside 12:40 Finding a same-day appointment through a network search 13:40 The CT report the AI refused to read 15:50 When trust erodes: good faith, not competence 18:41 Why switching hospitals wasn't an option 21:54 Defining quality of life: her three goals 28:27 Three Claude personas, and a local private tool 35:12 How to prompt: awareness, knowledge, advocacy — not diagnosis 37:54 Where AI fell short, and the closing asks THE AGENTIC PATIENT SERIES New to the series? Start here → [PASTE PREVIOUS AGENTIC PATIENT EPISODE LINK] All episodes → https://www.facesofdigitalhealth.com/agentic-patient-blog MORE FROM FACES OF DIGITAL HEALTH

Send us Fan MailGLP-1 drugs have produced some of the most consistent weight loss results medicine has ever seen. The business of actually getting them to patients is a different story entirely.David E. Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health, break down the CVS Caremark formulary reversal on CareTalk, examining what it reveals about the economics of GLP-1 coverage, and why emerging clinical research on cancer, long COVID, and addiction may push these drugs far beyond their original indication.

It's been one year since the U.S. Centers for Disease Control and Prevention, in an unprecedented move, dismissed all the members of its Advisory Committee on Immunization Practices (ACIP), kicking off what would turn out to be a very concerning and busy year for infectious disease specialists.  We're going to recap this turbulent period – which includes a resurgence of measles, an unusually rough flu season, the emergence of a new COVID strain and outbreaks of hantavirus and Ebola – with Dr. William Schaffner, one of the country's most frequently quoted medical experts on infectious disease, vaccination, and public health. As a member of ACIP for decades, Dr. Schaffner brings unique insight into the dismantling of the committee and the distrust of vaccines that lies at the root of the changes. As he explains to Raise the Line host Lindsey Smith, while many vaccine critics are beyond reach, there are those he describes as vaccine hesitant that may be persuadable if the right approach is taken. “Beyond providing facts, we have to listen to them and respond to their concerns and make them feel comfortable. Information is fundamental, but behavior change only comes with a change in attitude.” Tune in for a wealth of wisdom and context that includes observations on: What's complicating containment of the Ebola outbreak; Challenges in public health communication in the current social media environment; What grade health authorities should get on their response to the hantavirus outbreak. Mentioned in this episode:Vanderbilt University School of Medicine If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Ric Sinclair is the CEO of Cotiviti, an enterprise healthcare software and data company that serves hundreds of health plans — including the top 25 in the country — across payment integrity, interoperability, risk adjustment, value-based care, and member engagement, touching coverage for over 300 million patients and members. Cotiviti pairs algorithms and AI with thousands of clinical nurses, MDs, and content experts in a human-in-the-loop model, working across the full administrative ecosystem that moves between payers, providers, patients, and pharma. Ric's core conviction is that healthcare's central problem isn't a data problem or a technology problem — it's a coordination problem, and what the system has never had is a true infrastructure layer to tie it together. Cotiviti isn't trying to pick a side between payers and providers; the bet is that a neutral party sitting in the middle can drive fair, transparent outcomes and pull down the trillion-plus dollars of administrative waste in U.S. healthcare.We discuss:Why healthcare's core problem isn't a data problem or a technology problem — it's a coordination problem, and what it actually takes to build the first infrastructure layer the system has ever hadThe real difference between owning a decade of data assets (and the Edifecs integration) and becoming the infrastructure the industry runs on — and where Cotiviti is in that build todayHow "human in the loop" works at scale — pairing AI with thousands of nurses, MDs, and content experts so every claim is reviewed fairly and problems get predicted before they happenWhy Ric's answer to AI isn't "cut the 10-person team to 2" — it's "take all 10 and do what 50 could," and what that augment-don't-replace math means for client ROIHow you build trust and accountability into an AI workflow rather than bolting it on — and who's accountable when models start shaping decisions about claims and careHow to sit in the neutral middle between payers and providers who don't trust each other — and what it takes to build something both sides actually believe is fairWhat Ric learned as a working drummer in Nashville before healthcare found him — leading without the spotlight, making others better, and why simplicity is a discipline that transfers straight into businessWhat a truly differentiated healthcare platform looks like five years out — and the test Ric uses for what "winning" means: a family of five at the dinner table who never have to think about the administrative machinery behind their care—Brought to you by: Sage Growth Partners — Value-focused strategy and marketing for growth-driven healthcare organizations. — Where to find Jared: • X: https://x.com/jaredstaylor • LinkedIn: https://www.linkedin.com/in/jaredstaylor/

From Promise to Performance: Advancing Digital Health with Intention and Impact Host Russ Branzell, President and CEO of CHIME, is joined by Lyle McMillin, Associate Vice President of Product Management at Hyland, for a dynamic discussion on turning digital health ambition into measurable performance. The conversation examines how healthcare leaders translate innovation , particularly in cloud, AI, and enterprise imaging, into scalable, real-world use and impact. Lyle shares frontline insights on what's driving meaningful progress today, what's getting lost in the noise, and how organizations can build trust while navigating complex digital transformation decision. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Send us Fan MailSix million healthcare workers are missing today. By 2030, that number reaches 10 million. No amount of training will ever close that gap.In this clip from our episode “Is AI the New Dr. Google?”, host David E. Williams and Bertalan Mesko, Director of the Medical Futurist Institute, break down why the healthcare worker shortage is a mathematical problem that only advanced technology can solve.

At 25, Jace Yawnick was building a career in health and wellness sales, chasing growth, status, and the usual young adult fantasy of getting somewhere fast. Then his body stopped cooperating. Fatigue turned into chemotherapy. The diagnosis was primary mediastinal B cell non Hodgkin lymphoma, and the rest of his life split into before and after. Now in remission, he talks about cancer the way people actually live it, not the way nonprofits package it. He gets into survivorship, mental health, young adult isolation, and the deadening absurdity of prior authorization. One of the sharpest parts of the conversation lands on a simple American insult disguised as policy: treatment innovation means very little when insurance can still deny the scan, the drug, or the next step. Jace has seen that firsthand, including during routine monitoring after active treatment. This episode tracks what happens when a young cancer patient becomes a public voice and refuses to play mascot. It covers oncology, insurance, remission, advocacy, and the long mental hangover that follows survival. It also names the part too many institutions dodge: the system works great right up until it doesn't, and when it fails, patients get handed the bill, the panic, and a camera if they want anyone to care. RELATED LINKSJace Beats CancerJace Yawnick on LinkedImConquer Cancer ArticleCURE Today ArticlePyure BrandsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Healthcare AI funding is booming, but the money is flowing to fewer companies than ever before. As investors pour capital into a small group of breakout winners, founders are navigating a fundraising environment where expectations seem to change every quarter. Based on interviews with 24 healthcare founders and a dozen healthcare investors, Halle breaks down what is actually happening in the market today, from pitch meetings and diligence processes to the growing debate over whether AI has fundamentally changed venture capital itself. Why healthcare AI fundraising has become a tale of two marketsThe two questions dominating investor meetings in 2026The metrics VCs are looking for todayThe debate over whether investors should abandon traditional ownership targetsWhy high valuations can be both a gift and a trap for founders —Show notes:Submit questions for our Eric Larsen healthcare AI Q&A here Part I: AI ate digital health (and what that means for fundraising)Part II: Convicted or disciplined: How healthcare VCs are split on investing—

From Clinic to Consumer On How AI Is Reshaping the Entire Health Experience Host: Megan Antonelli Guest: Kenn Harper, GM, Dragon and DAX Copilot, Microsoft Join host Megan Antonelli who sits down with Kenneth Harper, General Manager for Dragon and DAX Copilot at Microsoft, to explore two major moves reshaping health AI. Dragon Copilot has now scaled to more than 100,000 clinical deployments across nine countries, spanning physician, nursing, and radiology workflows, while the newly launched Copilot Health gives patients a unified view of their health data from wearables, EHRs, and lab results, all between clinical visits. Kenneth unpacks what this dual-track strategy means for health systems, clinical teams, and patients, and what health system leaders need to be thinking about right now. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

At 20 years old, newly arrived from Puerto Rico and trying to build a future in science, Benjamin Suarez Jimenez found himself sitting in front of two senior faculty members accused of plagiarism. He knew the material. He had done the work. His mistake came from failing to cite class notes during an exam because nobody had told him that was expected. In a matter of minutes, he watched what felt like his entire career flash before him.On this episode of Standard Deviation, host Oliver Bogler examines the hidden architecture of academic science through the experiences of Dr. Benjamin Suarez Jimenez, Assistant Professor at the University of Rochester and a neuroscientist studying PTSD, anxiety, trauma, and spatial cognition through virtual reality and video game environments.Benjamin traces his path from Puerto Rico to the mainland United States, through the NIH, Columbia University, and eventually to leading his own laboratory. Along the way, he encountered a series of barriers that had little to do with scientific ability and everything to do with access to unwritten rules. From academic gatekeeping to grant writing expectations, he learned that success in biomedical research often depends on knowledge that never appears in a textbook.Oliver explores how those invisible obstacles shape careers, influence research funding, and determine who gains access to opportunity. The conversation also examines the Justice, Equity, Diversity, and Inclusion Program at the Life Science Editors Foundation, which pairs scientists from underrepresented backgrounds with experienced scientific editors. Through that mentorship, Benjamin transformed a critical grant proposal into a successful pilot award that helped launch an NIH R01 application.The discussion extends beyond one scientist's experience. Benjamin describes helping a former mentee navigate dissertation roadblocks that threatened her graduation, illustrating how institutional bureaucracy can delay careers and discourage talented researchers. Together, they explore the hidden administrative burden, cultural barriers, and bias that many scientists carry alongside their research, and what happens when someone who receives support turns around and opens the door for others.RELATED LINKSLife Science Editors FoundationBenjamin Suarez Jimenez LabDr. Benjamin Suarez JimenezBenjamin Suarez JimenezFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"Do nothing for us without us." According to today's guest Robyn Bussey, that operating principle is the basis for effective community health work. "You don't go into a community and dictate. You go and listen and trust and be a partner," she adds. As you'll learn in this enlightening conversation, Bussey is following that approach in her current work as Just Health Director at the Partnership for Southern Equity, an Atlanta-based nonprofit advancing racial equity and shared prosperity across the South.  On this episode of Raise the Line from Elsevier, Bussey provides illuminating  examples of community-rooted work in South Fulton County and rural Georgia, and explains why community health workers may be the most underutilized asset in addressing health disparities. This wide-ranging interview with host Michael Carrese also explores: Bussey's candid perspective on what happened to the surge of interest in health equity that occurred during COVID; Why life expectancy gains in many Southern states have lagged behind the rest of the country; Her advice to students and early-career clinicians about where they're needed most.   Mentioned in this episode:  Partnership for Southern Equity If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast